Artemether-80 Injection

In the 2026 clinical landscape, Artemether-80 Injection is a rapid-acting, lipid-soluble Artemisinin derivative. As a pharmacist and manufacturer at Healthy Life Pharma, I classify it as a potent “Schizontocide”—it is technically designed to clear malaria parasites from the blood faster than almost any other drug class.

It is specifically used for the treatment of severe and complicated malaria when oral medication is not possible.

1. Primary Therapeutic Indications

For your Healthy Inc marketplace dossiers, Artemether-80 is technically indicated for:

  • Severe Falciparum Malaria: Treating life-threatening malaria caused by Plasmodium falciparum, including cases involving cerebral malaria (brain involvement).

  • Multi-Drug Resistant (MDR) Malaria: It is the “Gold Standard” in geographical regions where the parasite has developed resistance to older drugs like Chloroquine or Quinine.

  • Transition Therapy: Used to rapidly reduce the parasite load in patients who are too ill or vomiting too much to take oral Artemisinin-based Combination Therapy (ACT).

2. Technical Mechanism: Oxidative Stress

From a manufacturing perspective at Healthy Life Pharma, Artemether works by turning the parasite’s own “meal” against it:

Heme Interaction: The parasite eats the host’s hemoglobin, releasing “heme” (which is toxic to the parasite).

Free Radical Generation: Artemether reacts with this heme to create reactive free radicals and singlet oxygen.

Cellular Sabotage: These radicals technically attack and destroy the parasite’s proteins and membranes, specifically targeting the food vacuole, leading to rapid death of the parasite.

3. The “Pharmacist’s Partner” Safety Protocols

Artemether-80 is an Oily Injection and requires strict 2026 Technical Standards:

  • Route of Administration: Strict Rule: It is for INTRAMUSCULAR (IM) USE ONLY. It must technically never be given intravenously (IV), as the oil-based solution can cause an embolism.

  • The “5-Day Course” Standard:

    • Day 1 (Loading): 3.2 mg/kg (usually 160 mg or 2 ampoules for an average adult).

    • Days 2–5: 1.6 mg/kg daily.

  • QT Prolongation Warning: It can technically affect heart rhythm. Avoid using it alongside other drugs that prolong the QT interval (like certain antidepressants or erythromycin).

  • Pregnancy Caution: While life-saving in severe cases, it is technically avoided in the first trimester unless the physician deems it essential to save the mother’s life, due to limited safety data.

4. Technical Profile: Storage & Side Effects

CategoryTechnical Specification
StorageStore below 30°C. Protect from light (it is light-sensitive).
AppearanceA clear, pale yellow oily solution.
Common Side EffectsDizziness, headache, and injection site pain.
Serious RisksRare cases of cardiotoxicity or transient fever.